News from Thursday, June 4, 2026
Articles
Video: Is Value-Based Insurance Design the Key to Affordable Healthcare?
(6/3, Health Affairs, YouTube) “Kim Westrich from the National Pharmaceutical Council argues that value-based insurance design is creating space for more ambitious thinking and deliberate health spending reforms amid rising concerns about healthcare affordability.” View Video
Video: Real-World Data Reveals Opportunities to Improve HER2-Low Metastatic Breast Cancer Care
(6/3, Jessica Paulus, ScD, Danielle Valletti, Pharmacy Times) “In this interview with Pharmacy Times, Jessica Paulus, ScD, Vice President, Real-World Research, Ontada, discusses emerging trends in HER2-low metastatic breast cancer care and the growing role of real-world evidence in improving treatment decision-making.” View Video
UK: NICE Clears New Drug for Platinum-Resistant Ovarian Cancer
(6/4, Medscape) reports “The National Institute for Health and Care Excellence (NICE) has recommended mirvetuximab soravtansine (Elahere, AbbVie) for treating folate receptor alpha-positive, platinum-resistant, high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer in adults who have received one to three prior lines of systemic treatment.” Full
Journals
Comparative Effectiveness of Tirzepatide Versus GLP-1 Receptor Agonists on the Risk of Venous Thromboembolism in Patients with Obesity: A Real-World Cohort Study
Jheng-Yan Wu, et al.
May 19, 2026, Frontiers in Medicine
Comparative Effectiveness of Triple Versus Dual Inhaled Therapy (ICS/LABA or LABA/LAMA) for Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-Analysis
Weimian Hu, Qinglin Li
June 4, 2026, BMC Pulmonary Medicine
Evaluating Treatment Sequences in Major Depressive Disorder Using an Open-Source Health Economic Model Based on Stakeholder and Patient Engagement
Alice Kate Cummings-Joyner, MS, et al.
June 4, 2026, Value in Health